Pe orheLLmee Si 12 ~ id feo Hes i be f ie TwDappTNoOrretpo|rt = nay STUDY OFTHEEFFECT OF PERFLUOROBUTANESULFONATE, 5 PEPRERFFLLUUOORROOHOEXCATNAESNUELSFOUNLAFTOEONNASNAODTME | ASPECTS OFCHOLESTEROLMETABOLISH INVITRO, b() 5 h SEe F Pine s - omy = o 3 EE NO_epor_of sFtudyiSWEOn T alverson TNCreport 16042008 | || | PERFSLTUUODRYOBOUFTTAHNEEESFUFLEFCOTNOAFTE, || PERFLUOROHEXANESULFONATE AND | PERFLUOROOCTANESULFONATE ON SOME ASPECTS OF CHOLESTEROL METABOLISM IN VITRO.
refid# 0gM0BX1nepxwDXQ4KDGgvvzvM35 pages
AR226-2042 lO:^^ ( WASHINGTON WORKS C-8 INDUSTRIAL HYGIENE A.
refid# ZZQ3jkNE7Gzd23x12061YnrO11 pages
AR226-2784 FOR DU POUT USE ONLY Copies to Haskell E.
refid# O7Oj37XgZBv76oMB3BGdMbNv8 pages
\ J - Copl;es to AR226-2857 Material Tested ------3 HaskelI HASKELL [ E.
refid# ypw3Nz6yobj9yyadpoMqbNj6E2 pages
FOR DU FONT USE ONLY AR226-2887 Copies Co E.
refid# 6wL06eL69yLz0r1xyjVYNmaG32 pages
AR 426_ 3310 rd -_-- --- TRADE SECRET Study Tie H-25357: BiopersistenceScreening 10-Dose Oral Gavage Study in Rats Laboratory Project ID: DuPont-11557 AR2RE 23/0 Dwupeonic1s55s7 AUTHOR: Carol Finlay, B.A.
refid# KD477EyEQBX0kgJr4dkpB2aK82 pages
EXECUTIVE SUMMARY - Detection Highlights cies amen mesmr RpevaorrIiG wots / DRRNTS Ba TER 03/13/07 13:05 901 orroons 0o.l0o0e7s333 0o.l01s0 uugg//LL wwe mame 03/13/07 07:55 002 pprroosn 00.0060696 33 o0.l0i1s0 uugg//LL DRRNTY SETTLED 03/33/07 07:55 003 roorns - 000008763 33 0o.l0o1i0s uugg//LL DRT?
refid# gDJk4Q484krm7gN2v2GgDVgvV2 pages
[Gambia Analytical Services- PrCirmeeda:ted1w5ith0A2ny2i034R1e.p0o00rFt2IeAr rEr N RCSummary Cmren| CC |ee d wer|d Foot woe soa| aa |wo| imam | ve mam|se |ow |omew| ve aans T[oommaenn|ww|| wee[ewweann|| wmow mi oes |aes|[men |] Page 202 01265 177 ASnoalluytmibciaal Services" Created vith Analyps.t2Reporter Printed: 15/02/2010 2:34.00 PM Quantitative Peak Review -7 7= -i fl3 K1000968-017 i T 0 irJ azs =5 2130P1F6BA9010a u Baseline o Missed | 21137C0-1P7F2B0A08 Baseline o Missed | | 263,P0F2P1E9A.01 0a Baseline c Missed | 31135C0-1PF2H7X0A0a Baseline 0 Missed dung 2a nbn Es Lig tered tld elo BreE LL 2 = f= i NE 209P.r0/e8s0100a CBaseline c Missed| 401380/01-0P3F.H0S0a cBaselineoMissed | | 313P0R/H2I6A010 0a oBaseinec Missed | 31153.C0-1P2F7H0i0XADa Baseline o Missed won ty Lay - Es i i Ei | ud L i f= = 363P.F01H6P9A.
refid# x1wnkb4VD6rG8wn40z4a5R986100 pages
3 : BE 3 Ec 35 2 bl Hl] HT : i: , 5 | i HH5 8 Err TTTT HHH : i f JE Lbbbbbllbblebbblbbblll :3 LEEEEEEEEEEEEEREE EEE ER EEREEE EEREREE Lt 33333993933999939939393NN
refid# 6wk9YOVE8DOXnDaOpVdkVyR2m125 pages
' .- 200 Chemical Solutions Enterprise P. 0.
refid# ZJOazvLRRV9q72D6VMmJ3bkVp2 pages
---------------------------------- | AR226-1404 || | | |i : - CC: POLYNERS OCCUPATIONAL KL oPY LIST BAA Thoey rpmongePsiOasLTYrAapAtEpeRpeS.
refid# NNkg7ajoM0o91X9ky3VLvjo3V10 pages
AR226- 1413 A 000003 Tennant Farm Herd Health lavestigation ariel rik Carle Team Repo.
refid# NG5Jzep7o70LvV7BVE1B8Nq0V224 pages
ARR2G -- 14-90 ee ose PROTOCOL Perfluorooctanoic Acid: Inhalation Repeated Dose Pharmacokinetic Study in the Rat Project Number: DuPont-12944 Work Request Number: 14552 Service Code Number: 1017 ig 2 on xz 33z8=5 3 shell Ail Wels Commitee No BTIS2P -- eee ------ FaTseTp-- r------ ---------- ret + PIenoharloatoiconiRaenpoeaitceAdciDdo:sePharmacoSktuidyninethteiRact TAOFBCOL NTENETS DuPon1204BR4 Page UG rrrsmsmssmmmm--------------} `SPONSE AA TES FAGHLY cvrrrnrarrsrnrrnnsnsmssssssssssssssnssson3 A TOS SUBSE:3 Be TES SYSIOM cnn 1.
refid# 0Gd3V0VVD4gvG4g5yeqvenrM13 pages
Oral Teratology Study of T-3141CoC in Rabbits RECEIVED FEliine Experiaent Nou: Conducted at: Dosing Period: Stuy director: {LTICZXCICOOLLSIGTYY4 osarmsesse SRSeia.keetTryaLuae,bvoairlanutasoterisiooenrs,sLaTboocr:atory NSoevpetaebaebrer6,21,19811981 througn E.G.
refid# 3NJ3QZpgZE9gGRDXJZyJN8gn29 pages
3Hmen wpr TECHNICAL REPORT SUMMARY =716/78 vo: recat communications cere ~ aman OR [GINA Importan=t frepisporinrtedton both side ofpaper, sen wocopie0 TCC.)
refid# jBvYND8aK5dqDrB4j7MVx1VYZ4 pages